Pathophysiology and prognosis in vietnamese adults with tuberculous meningitis.

The pathogenesis of tuberculous meningitis remains unclear, and there are few data describing the kinetics of the immune response during the course of its treatment. We measured concentrations of pro- and anti-inflammatory cytokines in serial blood and cerebrospinal fluid (CSF) samples from 21 adults who were being treated for tuberculous meningitis. CSF concentrations of soluble tumor necrosis factor-alpha receptors and of matrix metalloprotein-9 and its tissue inhibitor were also measured, and blood-brain barrier permeability was assessed by the albumin and IgG partition indices. CSF concentrations of lactate, interleukin-8, and interferon-gamma were high before treatment and then decreased rapidly with antituberculosis chemotherapy. However, significant immune activation and blood-brain barrier dysfunction were still apparent after 60 days of treatment. Death was associated with high initial CSF concentrations of lactate, low numbers of white blood cells, in particular neutrophils, and low CSF glucose levels.

[1]  F. Drobniewski,et al.  Isoniazid resistance, mycobacterial genotype and outcome in Vietnamese adults with tuberculous meningitis. , 2002, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[2]  P. Donald,et al.  The effect of adjuvant steroid treatment on serial cerebrospinal fluid changes in tuberculous meningitis , 2001, Annals of tropical paediatrics.

[3]  J. Farrar,et al.  Identification of a Matrix-Degrading Phenotype in Human Tuberculosis In Vitro and In Vivo1 , 2001, The Journal of Immunology.

[4]  K. Prasad,et al.  Steroids for treating tuberculous meningitis. , 2000, The Cochrane database of systematic reviews.

[5]  N. Day,et al.  Blood–brain barrier function in cerebral malaria and CNS infections in Vietnam , 2000, Neurology.

[6]  Y. Okada,et al.  Marked increase of matrix metalloproteinase 9 in cerebrospinal fluid of patients with fungal or tuberculous meningoencephalitis , 2000, Journal of the Neurological Sciences.

[7]  R. Appelberg,et al.  Neutrophils Play a Protective Nonphagocytic Role in Systemic Mycobacterium tuberculosis Infection of Mice , 2000, Infection and Immunity.

[8]  T. van der Poll,et al.  Elevated Chemokine Concentrations in Sera of Human Immunodeficiency Virus (HIV)-Seropositive and HIV-Seronegative Patients with Tuberculosis: a Possible Role for Mycobacterial Lipoarabinomannan , 1999, Infection and Immunity.

[9]  R. Young,et al.  Tumor necrosis factor α is a determinant of pathogenesis and disease progression in mycobacterial infection in the central nervous system , 1999 .

[10]  G. Sireci,et al.  Predominance of Vγ9/Vδ2 T Lymphocytes in the Cerebrospinal Fluid of Children with Tuberculous Meningitis: Reversal after Chemotherapy , 1999, Molecular medicine.

[11]  A. Karstaedt,et al.  Tuberculous meningitis in South African urban adults. , 1998, QJM : monthly journal of the Association of Physicians.

[12]  G. Kaplan,et al.  A combination of thalidomide plus antibiotics protects rabbits from mycobacterial meningitis-associated death. , 1998, The Journal of infectious diseases.

[13]  V. Vullo,et al.  Cerebrospinal fluid cytokines in patients with tuberculous meningitis. , 1997, Clinical immunology and immunopathology.

[14]  N. Mukaida,et al.  Elevated chemokine levels in bronchoalveolar lavage fluid of tuberculosis patients. , 1997, American journal of respiratory and critical care medicine.

[15]  E. Goetzl,et al.  Matrix metalloproteinases in immunity. , 1996, Journal of immunology.

[16]  K. Olsen,et al.  Concentrations of Interferon γ, Tumor Necrosis Factor α, and Interleukin-1β in the Cerebrospinal Fluid of Children Treated for Tuberculous Meningitis , 1995 .

[17]  J. Abrams,et al.  T-cell cytokine responses in human infection with Mycobacterium tuberculosis , 1995, Infection and immunity.

[18]  J. Rydberg,et al.  Assessment of a possible imbalance between tumor necrosis factor (TNF) and soluble TNF receptor forms in tuberculous infection of the central nervous system. , 1995, The Journal of infectious diseases.

[19]  P. Udani,et al.  Pathology and pathogenetic mechanisms in neurotuberculosis. , 1995, Radiologic clinics of North America.

[20]  W. Rom,et al.  Enhanced interleukin-8 release and gene expression in macrophages after exposure to Mycobacterium tuberculosis and its components. , 1995, The Journal of clinical investigation.

[21]  S. Harik.  Cerebrospinal Fluid in Diseases of the Nervous System, 2nd Ed. , 1994, Neurology.

[22]  P. Kragsbjerg,et al.  Tumor Necrosis Factor-α (TNFα) in Cerebrospinal Fluid from Patients with Meningitis of Different Etiologies: High Levels of TNFα Indicate Bacterial Meningitis , 1993 .

[23]  R. Fishman.  Cerebrospinal Fluid in Diseases of the Nervous System , 1992 .

[24]  D. Wallach,et al.  Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors , 1992, The Journal of experimental medicine.

[25]  M. Sande,et al.  Effects of ampicillin and corticosteroids on brain water content, cerebrospinal fluid pressure, and cerebrospinal fluid lactate levels in experimental pneumococcal meningitis. , 1985, The Journal of infectious diseases.

[26]  M. Lepper,et al.  THE PRESENT STATUS OF THE TREATMENT OF TUBERCULOSIS OF THE CENTRAL NERVOUS SYSTEM , 1963, Annals of the New York Academy of Sciences.

[27]  Streptomycin in Tuberculosis Trials Commitee.  STREPTOMYCIN treatment of tuberculous meningitis. , 1948, Lancet.

[28]  M. Loeb,et al.  Predictors of outcome in patients with tuberculous meningitis. , 2002, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[29]  R. Young,et al.  Tumor necrosis factor alpha is a determinant of pathogenesis and disease progression in mycobacterial infection in the central nervous system. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[30]  A. Mateczun,et al.  Tuberculosis meningitis, Abbassia Fever Hospital-Naval Medical Research Unit No. 3-Cairo, Egypt, from 1976 to 1996. , 1998, The American journal of tropical medicine and hygiene.

[31]  K. Olsen,et al.  Concentrations of interferon gamma, tumor necrosis factor alpha, and interleukin-1 beta in the cerebrospinal fluid of children treated for tuberculous meningitis. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[32]  H. Akalın,et al.  Cerebrospinal fluid interleukin-1 beta/interleukin-1 receptor antagonist balance and tumor necrosis factor-alpha concentrations in tuberculous, viral and acute bacterial meningitis. , 1994, Scandinavian journal of infectious diseases.

[33]  P. Kragsbjerg,et al.  Tumor necrosis factor-alpha (TNF alpha) in cerebrospinal fluid from patients with meningitis of different etiologies: high levels of TNF alpha indicate bacterial meningitis. , 1993, The Journal of infectious diseases.

[34]  H. V. Smith.  TUBERCULOUS MENINGITIS. , 1964, International journal of neurology.

[35]  I. Cathie,et al.  Streptomycin in the Treatment of Tuberculous Meningitis , 1950 .